JPMorgan Chase & Co’s Cellectar Biosciences CLRB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3
| Closed | -$24 | – | 6231 |
|
|
2025
Q1 | $24 | Sell |
3
-6,077
| -100% | -$48.6K | ﹤0.01% | 6215 |
|
|
2024
Q4 | $54.5K | Buy |
6,080
+5,308
| +688% | +$47.6K | ﹤0.01% | 4983 |
|
|
2024
Q3 | $49.6K | Sell |
772
-932
| -55% | -$59.9K | ﹤0.01% | 4984 |
|
|
2024
Q2 | $128K | Buy |
+1,704
| New | +$128K | ﹤0.01% | 4487 |
|
|
2024
Q1 | – | Sell |
-1
| Closed | -$55 | – | 6412 |
|
|
2023
Q4 | $55 | Buy |
+1
| New | +$55 | ﹤0.01% | 6152 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6138 |
|
|
2019
Q4 | – | Sell |
-35
| Closed | -$21K | – | 4705 |
|
|
2019
Q3 | $21K | Buy |
+35
| New | +$21K | ﹤0.01% | 4472 |
|